InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

20 October 2025

Name:	CLINUVEL PHARMACEUTICALS LIMITED (CUV)
ISIN:	AU000000CUV3
Date of Listing:	13 February 2001
Former Names:

Stock Exchange Status: (updated daily)

This entity is currently listed and quoted on the Australian Securities Exchange.

Legal Status: (updated monthly)

ACN: 089 644 119ABN: 88 089 644 119
Registration Date: 14 December 1999

This is a current registered entity, not in any form of external administration to our knowledge.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

CLINUVEL PHARMACEUTICALS LIMITED(CUV)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
CLINUVEL PHARMACEUTICALS LIMITED	01/03/2006
EPITAN LIMITED		01/03/2006

Shareholder links

Our website ranking of CUV:

(5 out of 5)

COMPANY WEBSITE:

CUV website

CUV email

CUV investorRelations

CUV announcements

CUV annualreports

CUV directors

REGISTRY:

Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000CUV3

Address: Level 22, 535 Bourke Street, Melbourne VIC 3000 Australia
Tel: 61 3 9660 4900 Fax: 61 3 9660 4999

Date first listed: 13/02/2001
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Pharmaceutical company focused on dermatology

News & Events

Expand this box to read and print

The suspension of trading in the securities of Clinuvel Pharmaceuticals Limited (the " Company") will be lifted immediately, following the release of an announcement regarding a capital raising. Security Code: CUV	06/05/2013
Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) has successfully raised A$6.3 million via a private placement to international institutional and professional investors ("Placement"). The Placement was conducted at price of A$2.136 per share, representing a 4.3% premium to the 20 day volume weighted average price on April 29 and 15.1% to the closing Price on April 30. There was strong participation in the Placement from institutional investors.	06/05/2013
The securities of Clinuvel Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. Security Code: CUV	03/05/2013
we understand that on or about this date the company consolidated its shares 1 for 10	12/11/2010
name changed from Epitan Limited	01/03/2006

OFX Transferring Money Internationally to Free

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
19/09/2023	Philippe Wolgen	1,850	$16.116	$29,814.00
26/06/2023	Philippe Wolgen	1,532	$17.720	$27,147.00
04/11/2022	Jeffrey Rosenfeld	300	$19.440	$5,832.00
16/06/2022	Brenda Shanahan	-15,000	$14.036	$210,536.00
07/06/2022	Brenda Shanahan	-22,392	$15.881	$355,606.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Jeffrey Rosenfeld	Chairman	26/11/2019
Philippe Wolgen	Managing Director, CEO	01/10/2005
Peter Vaughan	CFO, Company Secretary	16/04/2024
Guy van Dievoet	Non Exec Director	06/09/2024
Pearl Grimes	Non Exec Director	06/09/2024
Karen Agersborg	Non Exec Director	29/01/2018
Matthew Pringle	Non Exec Director	06/09/2024
Susan Smith	Non Exec Director	23/09/2019
Emilie Rodenburger	Director	22/04/2024
Claire Newstead-Sinclair	Company Secretary	06/08/2024

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.